Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Genotype-guided antithrombotic therapy].
van den Broek WWA, Azzahhafi J, van Schaik RHN, Ten Berg JM. van den Broek WWA, et al. Among authors: van schaik rhn. Ned Tijdschr Geneeskd. 2022 Jan 24;166:D6172. Ned Tijdschr Geneeskd. 2022. PMID: 35138719 Dutch.
[Pharmacogenetics in daily practice].
van Gelder T, van Schaik RHN. van Gelder T, et al. Among authors: van schaik rhn. Ned Tijdschr Geneeskd. 2020 Jun 4;164:D4191. Ned Tijdschr Geneeskd. 2020. PMID: 32608920 Dutch.
Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study.
Azzahhafi J, Bergmeijer TO, van den Broek WWA, Chan Pin Yin DRPP, Rayhi S, Peper J, Bor WL, Claassens DMF, van Schaik RHN, Ten Berg JM. Azzahhafi J, et al. Among authors: van den broek wwa, van schaik rhn. Front Pharmacol. 2022 Dec 5;13:1032995. doi: 10.3389/fphar.2022.1032995. eCollection 2022. Front Pharmacol. 2022. PMID: 36545312 Free PMC article.
Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.
van den Broek WWA, Azzahhafi J, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Dijksman LM, Walhout RJ, Gin MTJ, Breet NJ, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM. van den Broek WWA, et al. Among authors: van schaik rhn. Eur Heart J Cardiovasc Pharmacother. 2024 Nov 13:pvae087. doi: 10.1093/ehjcvp/pvae087. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39537191
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients.
van Schaik RH, Kok M, Sweep FC, van Vliet M, van Fessem M, Meijer-van Gelder ME, Seynaeve C, Lindemans J, Wesseling J, Van 't Veer LJ, Span PN, van Laarhoven H, Sleijfer S, Foekens JA, Linn SC, Berns EM. van Schaik RH, et al. Pharmacogenomics. 2011 Aug;12(8):1137-46. doi: 10.2217/pgs.11.54. Epub 2011 Aug 10. Pharmacogenomics. 2011. PMID: 21830868
422 results